806 related articles for article (PubMed ID: 24405586)
1. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil.
Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T
Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer.
Tominaga T; Tsuchiya T; Mochinaga K; Arai J; Yamasaki N; Matsumoto K; Miyazaki T; Nagasaki T; Nanashima A; Tsukamoto K; Nagayasu T
BMC Cancer; 2016 Jun; 16():354. PubMed ID: 27268079
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.
Nagasaki T; Tsuchiya T; Tagawa T; Honda S; Yamasaki N; Miyazaki T; Hidaka S; Hayashi T; Nagayasu T
Clin Lung Cancer; 2010 Nov; 11(6):412-22. PubMed ID: 21062732
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
Huang CL; Yokomise H; Kobayashi S; Fukushima M; Hitomi S; Wada H
Int J Oncol; 2000 Jul; 17(1):47-54. PubMed ID: 10853017
[TBL] [Abstract][Full Text] [Related]
6. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Hölscher AH; Danenberg PV; Brabender J
Clin Lung Cancer; 2010 Sep; 11(5):328-34. PubMed ID: 20837458
[TBL] [Abstract][Full Text] [Related]
7. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer.
Shintani Y; Ohta M; Hirabayashi H; Tanaka H; Iuchi K; Nakagawa K; Maeda H; Kido T; Miyoshi S; Matsuda H
Lung Cancer; 2004 Aug; 45(2):189-96. PubMed ID: 15246190
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung.
Ishihama H; Chida M; Araki O; Karube Y; Seki N; Tamura M; Umezu H; Honma K; Masawa N; Miyoshi S
Jpn J Clin Oncol; 2009 Jan; 39(1):33-6. PubMed ID: 19015148
[TBL] [Abstract][Full Text] [Related]
9. Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
Inoue K; Takao M; Watanabe F; Tarukawa T; Shimamoto A; Kaneda M; Sakai T; Fukushima M; Shimpo H; Yada I
Lung Cancer; 2005 Jul; 49(1):47-54. PubMed ID: 15949589
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, orotate phosphoribosyltransferase mRNA expression in lung cancer metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration: a pilot study.
Nakajima T; Yasufuku K; Suzuki M; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
Clin Lung Cancer; 2011 Sep; 12(5):293-7. PubMed ID: 21791367
[TBL] [Abstract][Full Text] [Related]
11. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: a prospective multi-institutional study in Japan.
Eguchi K; Oyama T; Tajima A; Abiko T; Sawafuji M; Horio H; Hashizume T; Matsutani N; Kato R; Nakayama M; Kawamura M; Kobayashi K
Lung Cancer; 2015 Jan; 87(1):53-8. PubMed ID: 25468199
[TBL] [Abstract][Full Text] [Related]
13. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
[TBL] [Abstract][Full Text] [Related]
14. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
[TBL] [Abstract][Full Text] [Related]
15. The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.
Oguri T; Achiwa H; Bessho Y; Muramatsu H; Maeda H; Niimi T; Sato S; Ueda R
Lung Cancer; 2005 Sep; 49(3):345-51. PubMed ID: 15993511
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
Schneider S; Uchida K; Brabender J; Baldus SE; Yochim J; Danenberg KD; Salonga D; Chen P; Tsao-Wei D; Groshen S; Hoelscher AH; Schneider PM; Danenberg PV
J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
[TBL] [Abstract][Full Text] [Related]
18. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
19. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
